Massachusetts Financial Services’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$238K Buy
+25,223
New +$202K ﹤0.01% 997
2016
Q2
– Sell
-183,368
Closed -$1.51M – 861
2016
Q1
$1.51M Buy
183,368
+2,322
+1% +$21.9K ﹤0.01% 711
2015
Q4
$3.14M Sell
181,046
-1,286
-0.7% -$19.1K ﹤0.01% 689
2015
Q3
$2.09M Buy
+182,332
New +$3.98M ﹤0.01% 721

Other funds holding IBRX

Massachusetts Financial Services's IBRX Position: Q3 2026 in Review

Massachusetts Financial Services opened a new position in ImmunityBio (IBRX) in Q3 2026: 25,223 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #997 among its holdings. This is a return to the name: Massachusetts Financial Services previously reported a position in IBRX as recently as Q1 2016.

Massachusetts Financial Services first reported a position in IBRX in Q3 2015 and has held it in 4 quarters since. The position peaked at $3.14M in Q4 2015. 404 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.

  • Massachusetts Financial Services held 25,223 shares of ImmunityBio worth $238K as of Q3 2026.
  • ImmunityBio was a new Massachusetts Financial Services position in Q3 2026.
  • ImmunityBio made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q3 2026, its #997 holding.
  • Massachusetts Financial Services first reported a position in ImmunityBio in Q3 2015 and has held it in 4 quarters since.
  • Massachusetts Financial Services's ImmunityBio position peaked at $3.14M in Q4 2015.
  • 404 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.

Based on Massachusetts Financial Services's 13F filing for Q3 2026, filed 12 Nov 2026.